Goldman Sachs’s Health Sciences Acquisitions Corporation Warrants HSACW Stock Holding History

Goldman Sachs’s Portfolio HSACW Stock Details HSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-29,180	Closed	-$25K	–	5529
2019 Q3	$25K	Buy	+29,180	New	+$26.6K	﹤0.01%	5098

Goldman Sachs's HSACW Position: Q4 2019 in Review

Goldman Sachs sold out of Health Sciences Acquisitions Corporation Warrants (HSACW) in Q4 2019, closing a stake of 29,180 shares — an estimated $25K sold.

Goldman Sachs first reported a position in HSACW in Q3 2019 and held it in 1 quarter. The position peaked at $25K in Q3 2019. 0 funds tracked by Wall St. Rank hold HSACW as of Q4 2019.

Goldman Sachs reported no remaining Health Sciences Acquisitions Corporation Warrants position as of Q4 2019 after selling out during the quarter.
Goldman Sachs sold 29,180 Health Sciences Acquisitions Corporation Warrants shares in Q4 2019, an estimated $25K.
Goldman Sachs first reported a position in Health Sciences Acquisitions Corporation Warrants in Q3 2019 and held it in 1 quarter.
Goldman Sachs's Health Sciences Acquisitions Corporation Warrants position peaked at $25K in Q3 2019.
0 funds tracked by Wall St. Rank held Health Sciences Acquisitions Corporation Warrants as of Q4 2019.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.